Expression of ER-a36, a novel variant of estrogen receptor a, and resistance to tamoxifen treatment in breast cancer

被引：0
|
作者：
Shi, L.
Dong, B.
Li, Z.
Lu, Y.
Ouyang, T.
Li, J.
Wang, T.
Fan, Z.
Fan, T.
Lin, B.
Wang, Z.
Xie, Y.
机构：
[1] Peking Univ, Beijing 100871, Peoples R China
[2] Creighton Univ, Sch Med, Omaha, NE USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：216S / 216S
页数：1
相关论文
共 50 条
  • [1] Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
    Shi, Liang
    Dong, Bin
    Li, Zhongwu
    Lu, Yunwei
    Tao Ouyang
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Wang, Zhaoyi
    Xie, Yuntao
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3423 - 3429
  • [2] Estrogen Receptor-α Variant, ER-α36, is Involved in Tamoxifen Resistance and Estrogen Hypersensitivity
    Zhang, XianTian
    Wang, Zhao-Yi
    ENDOCRINOLOGY, 2013, 154 (06) : 1990 - 1998
  • [3] Estrogen receptor β (ERβ) level but not its ERβcx variant helps to predict tamoxifen resistance in breast cancer
    Esslimani-Sahla, M
    Simony-Lafontaine, J
    Kramar, A
    Lavaill, R
    Mollevi, C
    Warner, M
    Gustallsson, JÅ
    Rochefort, H
    CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5769 - 5776
  • [4] Let-7 microRNAs Regulate a Novel Variant of Estrogen Receptor Alpha, ER-≥36, Nongenomic Estrogen Signal Pathway, and Tamoxifen Resistance in Breast Cancer
    Zhao, Y.
    Deng, C.
    Lu, W.
    Xiao, J.
    Recker, R. R.
    Guishan, G. G.
    CANCER RESEARCH, 2010, 70
  • [5] ER-α36, a variant of ER-α, is the estrogen receptor that mediates mitogenic estrogen signaling in breast cancer cells
    Ding, L.
    Zhang, X. T.
    Wang, Z. Y.
    CANCER RESEARCH, 2009, 69 (02) : 68S - 68S
  • [6] "Dwarf" Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen
    Fowler, Amy M.
    Santen, Richard J.
    Allred, D. Craig
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3413 - 3415
  • [7] Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer
    Maczis, Melissa A.
    Maceyka, Michael
    Waters, Michael R.
    Newton, Jason
    Singh, Manjulata
    Rigsby, Madisyn F.
    Turner, Tia H.
    Alzubi, Mohammad A.
    Harrell, J. Chuck
    Milstien, Sheldon
    Spiegel, Sarah
    JOURNAL OF LIPID RESEARCH, 2018, 59 (12) : 2297 - 2307
  • [8] Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells
    Qu, Chao
    Ma, Jingyun
    Zhang, Yejun
    Han, Chao
    Huang, Liang
    Shen, Liming
    Li, Hongyan
    Wang, Xiaobo
    Liu, Jing
    Zou, Wei
    CANCER SCIENCE, 2019, 110 (01) : 221 - 234
  • [9] ER?α 36 a variant of estrogen receptor er?α 66 is expressed in human gastric cancer
    Deng, H.
    Huang, X.
    Fan, J.
    Wang, L. B.
    Xia, Q.
    Yang, X. P.
    Wang, Z. Y.
    Liu, L. J.
    HISTOPATHOLOGY, 2010, 57 : 193 - 193
  • [10] Expression of ER-α36, a Novel Variant of Estrogen Receptor in Endometrial Carcinoma and Its Clinical Significance
    Sun, Lifang
    Wang, Jianliu
    Zhang, Lili
    Li, Xiaoping
    Shen, Danhua
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2013, 75 (01) : 68 - 72
12345